Go Deep
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,282 | -0.5 | 0.47 | 0.01 | 583.78 |
| Oct 2026 | 22,207 | -0.5 | 0.49 | 0.01 | 607.66 |
| Oct 2026 | 22,201 | -0.5 | 0.49 | 0.01 | 609.65 |
| Oct 2026 | 22,300 | -0.5 | 0.47 | 0.01 | 572.08 |
| Oct 2026 | 22,187 | -0.4 | 0.44 | 0.01 | 543.30 |
| Oct 2026 | 22,173 | -0.4 | 0.45 | 0.01 | 548.04 |
| Oct 2026 | 22,272 | -0.4 | 0.42 | 0.01 | 513.58 |
| Oct 2026 | 22,356 | -0.4 | 0.40 | 0.01 | 484.22 |
Tonix Pharmaceuticals Holding Corp. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 13,544,000.0 | 6,878,000.0 | 5,390,000.0 | 3,290,000.0 |
| Net Profit | -40,552,000.0 | -40,194,000.0 | -46,910,000.0 | -32,010,000.0 |
| EPS | -2.4 | -2.9 | -4.0 | -3.6 |
Tonix Pharmaceuticals Holding Corp. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 13,107,000.0 | 10,094,000.0 | 7,768,000.0 | 0.0 | — |
| Net Profit | -124,021,000.0 | -130,036,000.0 | -116,658,000.0 | -110,218,000.0 | — |
| EPS | -14.6 | -176.6 | -14,720.2 | -65,400.0 | — |
Tonix Pharmaceuticals Holding Corp. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 277,171,000.0 | 162,890,000.0 | 154,457,000.0 | 225,690,000.0 | — |
| Total Liabilities | 32,021,000.0 | 23,332,000.0 | 48,932,000.0 | 18,508,000.0 | — |
| Total Equity | 245,150,000.0 | 139,558,000.0 | 105,525,000.0 | 207,182,000.0 | — |
Owes vs Owns
Tonix Pharmaceuticals Holding Corp. owed $0.13 for every $1 it owned in Jun 2026, up from $0.08 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.13× | 0.12× | 0.14× | 0.32× | 0.08× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Tonix Pharmaceuticals Holding Corp. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 74.9%Receivables 3.7%Inventory 2.5%Fixed assets (tangible) 16.6%Other assets 2.2%
How it's funded — Dec 2025
Payables 2.9%Other liabilities 8.2%Shareholders' equity 88.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 207.6 | 98.8 | 24.9 | 120.2 |
| Receivables | 10.3 | 8.6 | 6.1 | 8.0 |
| Inventory | 7.0 | 8.4 | 14.1 | 0.0 |
| Fixed assets (tangible) | 46.0 | 42.8 | 94.9 | 94.5 |
| Intangible assets | 0.1 | 0.1 | 10.7 | 0.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 6.1 | 4.1 | 3.7 | 2.8 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 3.1 | 2.6 | 0.4 |
| Long-term debt | 1.2 | 4.7 | 6.6 | 0.3 |
| Payables | 8.1 | 4.5 | 3.8 | 8.1 |
| Other liabilities | 22.6 | 11.0 | 36.0 | 9.7 |
| Shareholders' equity | 245.2 | 139.6 | 105.5 | 207.2 |
| Net tangible assets | 245.0 | 139.4 | 94.8 | 207.1 |
Tonix Pharmaceuticals Holding Corp. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -99,844,000.0 | -60,925,000.0 | -102,003,000.0 | -98,053,000.0 | — |
| Investing Activities | -4,528,000.0 | -120,000.0 | -29,070,000.0 | -48,147,000.0 | — |
| Financing Activities | 214,530,000.0 | 134,872,000.0 | 36,517,000.0 | 87,844,000.0 | — |